Evidence map›Paper›PMID 35499668›Full record

ArticleAnnals of nuclear medicine2022

Thyroid function after diagnostic

Sarah C Clement, Godelieve A M Tytgat, A S Paul van Trotsenburg, Leontien C M Kremer, Hanneke M van Santen

Open access · hybridAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Annals of nuclear medicine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.4field-weighted citation impact, top 40% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 3 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 1 country.

Sarah C ClementDepartment of Pediatrics, Emma Children's Hospital, Amsterdam UMC, Amsterdam, The Netherlands.
Godelieve A M TytgatPrincess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.
A S Paul van TrotsenburgDepartment of Pediatric Endocrinology, Emma Children's Hospital, Amsterdam UMC, Amsterdam, The Netherlands.
Leontien C M KremerPrincess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.
Hanneke M van SantenDepartment of Pediatric Endocrinology, Wilhelmina Children's Hospital, University Medical Center Utrecht, PO Box 85090, 3508 AB, Utrecht, The Netherlands. h.m.vansanten@umcutrecht.nl.
Princess Máxima Center · NLAmsterdam University Medical Centers · NLEmma Kinderziekenhuis · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundMetaiodobenzylguanidine (MIBG) labeled with radioisotopes can be used for diagnostics

methodsThyroid function and uptake of

resultsAfter a median follow-up of 6.6 years, thyroid function was normal in 46 of 48 survivors (95.8%). Two survivors [prevalence 4.2% (95% CI 1.2-14.0)] had mild thyroid dysfunction. In 29.2% of the patients and 11.1% of images

conclusionsThe prevalence of thyroid dysfunction does not seem to be increased in patients with neuroblastic tumors who received

Indexed as

3-IodobenzylguanidineNeuroblastomaChildHumansIodine RadioisotopesPotassium IodideThyroid Gland3-IodobenzylguanidineIodine-123Iodine RadioisotopesPotassium Iodide123I-metaiodobenzylguanidineHypothyroidismNeuroblastic tumorsNeuroblastomaRadiation damageThyroid function

Identifiers

PMID35499668
PMCPMC9132835
OpenAlexW4225274141

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.